KAPA Kairos Pharma, Ltd.

$0.29

Kairos Pharma, Ltd. (KAPA) SEC Filings

Everything KAPA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

3 filings
Date Form Filing
8-K GOVERNANCE_CHANGE
8-K REG_FD
8-K OTHER

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.